Core Viewpoint - Tianlong Co., Ltd. is facing regulatory scrutiny regarding its acquisition of Suzhou Haomibo Technology Co., Ltd. for over 230 million yuan, raising concerns about the transaction's rationale, valuation, and potential impact on future earnings [2][6]. Group 1: Transaction Details - The acquisition consists of two parts: a cash purchase of 132 million yuan for 32.30% equity and a capital increase of 100 million yuan to acquire an additional 33.33% equity [5]. - Upon completion, Tianlong will hold 54.87% of Suzhou Haomibo, which will become a subsidiary included in the consolidated financial statements [6]. Group 2: Financial Projections and Valuation - The static payback period for the investment is approximately 7.9 years, with expectations of continued losses for Suzhou Haomibo in 2026 and 2027, which may negatively affect Tianlong's performance in the next 2 to 3 years [6][8]. - Tianlong anticipates that Suzhou Haomibo's net profit will reach 98 million yuan annually once it stabilizes, translating to a 23.15% return on the investment of 232 million yuan, exceeding the company's projected return on equity of 7.56% for 2024 [6][8]. Group 3: Regulatory Concerns and Responses - The high valuation of Suzhou Haomibo, estimated at 354.7 million yuan, has drawn regulatory inquiries, with Tianlong asserting that the income approach better reflects the company's true value [8]. - Tianlong's revenue projections for Suzhou Haomibo suggest a compound annual growth rate of 41.29% from 2026 to 2030, with expected revenues of 438 million yuan and 500 million yuan in 2029 and 2030, respectively [8][9]. Group 4: Production Capacity and Market Outlook - Suzhou Haomibo's existing production capacity is designed for 1 million units annually, with plans to expand to 5.5 million units by 2032 through the establishment of new production lines [9]. - The company projects that its revenue will remain robust, with significant contributions from existing vehicle models and potential projects, despite a gradual decrease in growth rates [9][10]. Group 5: Risk Management and Sensitivity Analysis - The discount rate used for valuation is set at 11.75%, which is higher than the industry average, indicating a conservative approach to risk assessment [10]. - Sensitivity analysis shows that lowering the discount rate to 10.25% would increase the valuation by 31.27%, suggesting that the current valuation adequately covers potential risks [10].

Core Viewpoint - Tianlong Co., Ltd. announced a plan to acquire a controlling stake in Suzhou Haomibo Technology Co., Ltd. for 232 million yuan, raising regulatory concerns regarding insider trading and the valuation of the deal [2][3]. Group 1: Transaction Details - The acquisition consists of two parts: a cash purchase of 132 million yuan for 32.30% equity and a capital increase of 100 million yuan to obtain an additional 33.33% equity, resulting in a total ownership of 54.87% [3]. - The funding for the transaction is entirely sourced from Tianlong's own funds [3]. - Tianlong primarily operates in precision molds and injection parts, serving major automotive suppliers, and aims to enter the smart sensing field through this acquisition [3]. Group 2: Financial Performance and Projections - Suzhou Haomibo's R&D expenses for 2024 are projected at 34.06 million yuan, with 22.05 million yuan spent in the first nine months of 2025, leading to temporary losses [7]. - Revenue for Suzhou Haomibo in the first nine months of 2025 is expected to reach 33.79 million yuan, a 288.64% increase compared to the entire year of 2024 [7]. - The company has set ambitious revenue targets of 1.2 billion yuan and net profits of 48 million yuan from 2026 to 2029 [11]. Group 3: Valuation Concerns - The valuation of Suzhou Haomibo at 355 million yuan significantly contrasts with its negative net asset value and raises questions about the high premium associated with the acquisition [8][14]. - The transaction employs differentiated pricing, with external shareholders' equity valued at 446 million yuan, while the controlling shareholder's equity is valued at only 200 million yuan [9]. - Historical valuations show significant fluctuations, with the latest transaction price being approximately 45% lower than the previous B+ round valuation of 650 million yuan [11]. Group 4: Regulatory Scrutiny - The Shanghai Stock Exchange has issued multiple inquiries regarding the potential impact of the acquisition on Tianlong's future performance and the rationale behind the high valuation despite the risks of goodwill impairment and unmet performance commitments [12][14]. - Concerns have been raised about the revenue projections being overly optimistic, particularly regarding the assumptions made about order fulfillment rates and production capacity [15]. - The exchange has requested further clarification on the exit arrangements for external investors and the potential implications for minority shareholders [16].